Project Grant HT94252410364
Award Date
5/15/24
Completion Date
5/14/26
Dollars Obligated
$358K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
The U.S. Defense Health Agency awarded a $825,000 Project Grant to Delix Therapeutics, Inc. in Palo Alto, CA under the Military Medical Research and Development program (CFDA 12.420). The funding will support the "DEVELOPMENT OF SMALL-MOLECULE TREATMENT FOR HEARING LOSS" over a 3-year period from June 1, 2024 to May 31, 2027. The Military Medical Research and Development program provides grants to academic institutions, research centers, and medical universities to conduct biomedical...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $371,627 to the University of Texas Medical Branch at Galveston (UTMB) to support research on "TARGETING RETINOID ACID METABOLIC PATHWAY TO TREAT NOISE-INDUCED HEARING LOSS". The research aims to investigate the use of selective CYP26 inhibitors as a treatment for noise-induced hearing loss, with potential to transform care for Service Members and...
The Department of the Army Medical Command awarded Case Western Reserve University a $402,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support the repurposing of a therapeutic candidate to mitigate synaptopathy and associated hearing loss. The two-year award, beginning September 1, 2021, will fund research activities at Case Western Reserve University and its affiliated University Hospitals of Cleveland location in Cleveland, Ohio to...
The Defense Health Agency has awarded a $1,370,529 Cooperative Agreement under the Military Medical Research and Development program (CFDA 12.420) to the Massachusetts Eye and Ear Infirmary. The funding supports a 3-year project to investigate the regeneration of synapses to treat synaptopathy (damage to synaptic connections) following noise exposure, with the goal of transforming healthcare for Service Members and the American public. As a sub-award under this grant, The Geneva Foundation...
This $1.42M Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Miami to prevent hidden hearing loss and synaptopathy following noise overexposure through targeted temperature management. The 3-year grant, awarded on July 15, 2023, will fund this study focused on improving medical solutions for the battlefield and transforming health care for Service Members and the public through...
The federal Project Grant award in the amount of $357,989.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research on "MAGNETOPHOTOTHERMAL NANOPARTICLE DRUG DELIVERY FOR TREATING NOISE-INDUCED HEARING LOSS". The grant was awarded to the University of Cincinnati, a prominent research institution, with a performance period from September 1, 2025 to August 31, 2027. The project aims to develop innovative...
The Department of the Army Medical Command awarded a $1,437,602 Project Grant to The Trustees of Columbia University in New York, NY under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support development of novel gene and RNA therapies to prevent and restore noise-induced hearing loss. Specifically, researchers will develop long-term gene therapy and short-term siRNA products targeting the NOX3 pathway and validate efficacy and safety in auditory...
The Project Grant award in the amount of $1,170,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award will fund research conducted by the Regents of the University of Michigan to develop systemically administered bispecific antibodies that activate neurotrophin receptors for treating noise-induced inner ear damage. The research aims to transform healthcare for military service members and the broader...
This $402,500 Project Grant was awarded on May 1, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research by Case Western Reserve University (CWRU) to repurpose an FDA-approved drug to mitigate noise-induced hearing loss. CWRU is a private research university with a history of providing critical research, scientific, and technical services to federal agencies. The grant will fund CWRU's research over a...
The U.S. Department of Defense awarded a $350,848 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of Michigan to fund a 2-year research project titled "A Novel Strategy to Prevent Central Auditory Disorders After Blast Exposure." The project aims to develop a nanoparticle-based delivery system to administer therapeutics that can prevent hearing loss and other auditory impairments resulting from blast exposures...